期刊文献+

中医特色护理联合以问题为导向的细节干预对化疗后肝癌患者的影响 被引量:5

下载PDF
导出
摘要 目的:探讨中医特色护理联合以问题为导向的细节干预对化疗后肝癌患者的影响。方法:将2020年7月1日~2021年1月1日接受化疗的肝癌患者150例采用随机数字表法分为观察组74例和对照组76例,对照组采用常规护理,观察组采用中医特色护理联合以问题为导向的细节干预;比较两组不良事件发生情况、干预前后心理痛苦指数[采用心理痛苦温度计(DT)]、自护能力[采用自我护理能力测量量表(ESCA)]及生活质量[采用恶心呕吐生活功能指数问卷(FLIE)]。结果:观察组不良事件发生情况优于对照组(P<0.05);干预后第2、5周,观察组DT评分低于对照组(P<0.01);干预后第5周,两组ESCA中自我护理技能、自护责任感、自我概念、健康知识水平得分均高于干预前(P<0.05),且观察组高于对照组(P<0.01);干预后第5周,两组FLIE中恶心、呕吐得分均高于干预前(P<0.05),且观察组高于对照组(P<0.01)。结论:中医特色护理联合以问题为导向的细节干预可改善化疗后肝癌患者的恶心呕吐反应,降低不良事件等级,提高患者的生活质量,值得在临床护理中推广。
出处 《齐鲁护理杂志》 2022年第17期98-101,共4页 Journal of Qilu Nursing
  • 相关文献

参考文献12

二级参考文献90

  • 1赵忠斌,魏振平,芮伟.化疗止吐临床治疗药物新进展[J].世界临床药物,2006,27(8):480-484. 被引量:35
  • 2Fu MR, Rhodes V,Xu B. The Chinese translation of the Index ofNausea, Vomiting, and Retching [J].Cancer nursing, 2002, 25(2): 134-140.
  • 3Windle PE,Borromeo A,Robles H,et al. The effects ofacupressure on the incidence of postoperative nausea and vomiting inpostsui^ieal patients [J].J Perianesth Nure, 2001, 16 (3) : 158-162.
  • 4Z6rate E, Mingus M, White PF,et al. The use of transcutaneousacupoint electrical stimulation for preventing nausea and vomiting afterlaparoscopic surgery [ J ].Anesth Analg, 2001,92 ( 3 ): 629.
  • 5Morrow, GR. Methodology in behavioral and psychosocial cancerresearch. The assessment of nausea and vomiting. Past problemscurrent issues and suggestion for future research [ J ].Cancer,1984, 53 (10) : 2267 -2280.
  • 6Pongrojpaw D, Chiamchanya C. The efficacy of ginger in prevention ofpost - operative nausea and vomiting after outpatient gynecologicallaparoscopy [ J].J Med Assoc Thai, 2003, 86 (3) : 244 - 250.
  • 7Badar T, Cortes J, Borthakur G, et al. Phase 11, open label, randomized comparative trial of ondansetron alone versus the combination of ondansetron and aprepitant for the prevention of nausea and vomiting in patients with hematologic malignancies receiving regimens containing high-dose cytarabine [J]. Biomed Res Int, 2015, 2015: 497597.
  • 8Jahn F, Riesner A, Jahn P, et al. Addition of the neurokinin - 1-receptor antagonist (RA) aprepita nt to a 5-hydroxy tryptamine-RA and dexametha sone in the prophylaxis of nausea and vomiting due to radiation therapy with concomitant cisplatin [J]. Int J Radiat Oncol Biol Phys, 2015, 92 (5): 1101-1107.
  • 9Kawaguchi R, Tanase Y, Haruta S, et al. Addition of aprepitant to standard therapy for prevention of nausea and vomiting among patients with cervical cancer undergoing concurrent chemoradiotherapy [J]. Int J Gynaecol Obstet, 2015, 131 (3) 312-313.
  • 10Rapoport BL. Efficacy of a triple antiemetic regimen with aprepitant for the prevention of chemotherapy-induced nausea and vomiting: effects of gender, age, and region [J]. Curr MedResOpin, 2014, 30 (9): 1875-1881.

共引文献201

同被引文献79

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部